Ambev (ABEV) to Release Quarterly Earnings on Thursday

Ambev (NYSE:ABEV) is projected to post its Q2 2026 results before the market opens on Thursday, July 30th. Analysts expect Ambev to announce earnings of $0.04 per share and revenue of $4.0501 billion for the quarter. Parties can check the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Wednesday, July 29, 2026 at 8:00 AM ET.

Ambev (NYSE:ABEV) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $0.05 EPS for the quarter, meeting the consensus estimate of $0.05. The company had revenue of $4.32 billion for the quarter, compared to analyst estimates of $4.38 billion. Ambev had a net margin of 17.69% and a return on equity of 16.63%. On average, analysts expect Ambev to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Ambev Price Performance

Shares of ABEV opened at $3.15 on Thursday. The business’s 50-day moving average is $3.14 and its two-hundred day moving average is $3.01. The company has a market capitalization of $49.73 billion, a P/E ratio of 16.61, a P/E/G ratio of 1.82 and a beta of 0.64. The company has a debt-to-equity ratio of 0.02, a quick ratio of 0.78 and a current ratio of 1.03. Ambev has a fifty-two week low of $2.10 and a fifty-two week high of $3.45.

Ambev Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, January 11th. Stockholders of record on Wednesday, June 24th will be issued a $0.0092 dividend. This represents a $0.04 annualized dividend and a dividend yield of 1.2%. The ex-dividend date of this dividend is Wednesday, June 24th. Ambev’s payout ratio is 10.53%.

Insider Activity

In other news, insider Paulo Andre Zagman sold 136,250 shares of the stock in a transaction dated Tuesday, May 5th. The shares were sold at an average price of $3.41, for a total transaction of $464,612.50. Following the sale, the insider directly owned 230,535 shares of the company’s stock, valued at $786,124.35. This represents a 37.15% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Hedge Funds Weigh In On Ambev

A number of large investors have recently bought and sold shares of the business. Integrated Wealth Concepts LLC acquired a new stake in Ambev in the first quarter valued at approximately $26,000. Millennium Management LLC raised its stake in shares of Ambev by 62.5% during the 1st quarter. Millennium Management LLC now owns 2,399,472 shares of the company’s stock worth $5,591,000 after buying an additional 922,566 shares during the period. Goldman Sachs Group Inc. raised its stake in shares of Ambev by 13.2% during the 1st quarter. Goldman Sachs Group Inc. now owns 5,000,107 shares of the company’s stock worth $11,650,000 after buying an additional 582,153 shares during the period. Focus Partners Wealth purchased a new position in shares of Ambev during the 1st quarter valued at approximately $33,000. Finally, Acadian Asset Management LLC purchased a new position in shares of Ambev during the 1st quarter valued at approximately $264,000. Institutional investors and hedge funds own 8.13% of the company’s stock.

Analyst Ratings Changes

A number of analysts have recently commented on the company. Barclays upped their target price on Ambev from $3.00 to $3.50 and gave the stock an “equal weight” rating in a research note on Wednesday, May 6th. UBS Group boosted their price target on Ambev from $2.65 to $2.90 and gave the company a “sell” rating in a report on Thursday, May 14th. Wall Street Zen downgraded Ambev from a “buy” rating to a “hold” rating in a report on Monday, July 13th. Weiss Ratings lowered Ambev from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Wednesday, May 6th. Finally, Scotiabank cut shares of Ambev from a “sector outperform” rating to a “sector perform” rating in a research note on Wednesday, July 15th. Six investment analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Ambev has a consensus rating of “Reduce” and a consensus target price of $3.09.

Ambev Company Profile

Ambev (NYSE: ABEV) is a Brazilian-based beverage company that produces, distributes and markets a broad portfolio of alcoholic and non-alcoholic drinks. The company’s core business centers on brewing and selling beer, alongside a range of soft drinks, bottled water, energy drinks and other malt-based beverages. Headquartered in São Paulo, Ambev operates an integrated value chain that covers manufacturing, packaging, logistics and commercial sales to retail, on-premise and institutional customers.

The company traces its origins to the 1999 merger of two historic Brazilian breweries, and later became part of the broader global brewing group through subsequent industry consolidations.